These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 23815959
1. Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo. Kanwar AJ, Mahajan R, Parsad D. J Cutan Med Surg; 2013; 17(4):259-68. PubMed ID: 23815959 [Abstract] [Full Text] [Related]
2. Oral mycophenolate mofetil as a stabilizing treatment for progressive non-segmental vitiligo: results from a prospective, randomized, investigator-blinded pilot study. Bishnoi A, Vinay K, Kumaran MS, Parsad D. Arch Dermatol Res; 2021 Jul; 313(5):357-365. PubMed ID: 32737577 [Abstract] [Full Text] [Related]
3. A Randomized Comparative Study of Oral Corticosteroid Minipulse and Low-Dose Oral Methotrexate in the Treatment of Unstable Vitiligo. Singh H, Kumaran MS, Bains A, Parsad D. Dermatology; 2015 Jul; 231(3):286-90. PubMed ID: 26278124 [Abstract] [Full Text] [Related]
4. Oral dexamethasone pulse treatment for vitiligo. Radakovic-Fijan S, Fürnsinn-Friedl AM, Hönigsmann H, Tanew A. J Am Acad Dermatol; 2001 May; 44(5):814-7. PubMed ID: 11312430 [Abstract] [Full Text] [Related]
5. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Pasricha JS, Khaitan BK. Int J Dermatol; 1993 Oct; 32(10):753-7. PubMed ID: 8225724 [Abstract] [Full Text] [Related]
6. Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris. Singh A, Kanwar AJ, Parsad D, Mahajan R. Indian J Dermatol Venereol Leprol; 2014 Oct; 80(1):29-35. PubMed ID: 24448120 [Abstract] [Full Text] [Related]
7. A Retrospective Study of Methylprednisolone Mini-Pulse Therapy Combined with Narrow-Band UVB in Non-Segmental Vitiligo. Lee J, Chu H, Lee H, Kim M, Kim DS, Oh SH. Dermatology; 2016 Oct; 232(2):224-9. PubMed ID: 26431053 [Abstract] [Full Text] [Related]
8. Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo. Seiter S, Ugurel S, Tilgen W, Reinhold U. Int J Dermatol; 2000 Aug; 39(8):624-7. PubMed ID: 10971735 [Abstract] [Full Text] [Related]
12. Effect of intravenous pulse dexamethasone versus daily oral prednisolone on bone mineral density in dermatology patients: Is it a site-specific response? Handa S, Singh G, Arora AK, Khandelwal N, Gupta V. Indian J Dermatol Venereol Leprol; 2018 Aug; 84(2):174-178. PubMed ID: 28397714 [Abstract] [Full Text] [Related]
14. The role of systemic steroids and phototherapy in the treatment of stable vitiligo: a randomized controlled trial. El Mofty M, Essmat S, Youssef R, Sobeih S, Mahgoub D, Ossama S, Saad A, El Tawdy A, Mashaly HM, Saney I, Helal R, Shaker O. Dermatol Ther; 2016 Nov; 29(6):406-412. PubMed ID: 27528547 [Abstract] [Full Text] [Related]
17. The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients. Kim SM, Lee HS, Hann SK. Int J Dermatol; 1999 Jul; 38(7):546-50. PubMed ID: 10440289 [Abstract] [Full Text] [Related]
19. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study. Parmar NV, Kanwar AJ, Minz RW, Parsad D, Vinay K, Tsuruta D, Ishii N, Hashimoto T. Indian J Dermatol Venereol Leprol; 2013 Jul; 79(1):70-6. PubMed ID: 23254732 [Abstract] [Full Text] [Related]
20. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir. Dogra S, Kumar B. Dermatol Online J; 2005 Dec 01; 11(3):30. PubMed ID: 16409926 [Abstract] [Full Text] [Related] Page: [Next] [New Search]